Evexia Lifecare Stock: price and insider trades · India

Evexia Lifecare, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). 3 insiders have disclosed 15 filings since 7 November 2025.

Purchases and sales both appear in the filings: 14 purchases (2 insiders, €983k) and 1 sale (1 insider). No amount is published for 4 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 major shareholder among the declarants. The largest single trade was a purchase of €349k by Shree Saibaba Exim Private Limited, published on 8 September 2026, equal to 1.1% of the market capitalisation.

The last insider purchase was made public on 1 October 2026, 38 days ago. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public.

For context, the typical company on the same exchange (median of 1,913 companies) published 4 filings over the same period, against 15 filings here. Our records for Evexia Lifecare go back to 2026, with 14 purchases and 1 sale on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.